GZERO Summit on the Fight Against Covid-19
Key-Panel Discussion*1
20:30 – 21:15 Dec 8 EST / 10:30 – 11:15 Dec 9 JST
Roundtable Discussion*2
21:30 – 23:00 Dec 8 EST / 11:30 – 13:00 Dec 9 JST
The development and distribution of therapeutic drugs and vaccines are needed to contain the spread of the coronavirus. While international cooperation such as the ACT-Accelerator program has made significant progress, it still seems insufficient. One major risk is that countries are promoting their own vaccines, competing with one another rather than seeking to cooperate.
What more can leading governments do, and what is the proper role of international organizations such as the WHO? Of inter-governmental forums such as the G7 and G20? NGOs? Companies? What actions should be taken to enhance multilateral cooperation?
Guiding Questions
Global containment and eradication: What is the most effective approach for the global fight against Covid-19? What have key public and private stakeholders done, and what should they do going forward?Economic effects of Covid-19: How has the economy been affected by and responded to Covid-19? What will the situation look like going forward?
Next steps in the collective response and global fight against Covid-19: What implications do the proposed program to vaccinate all citizens—and a lack of global leadership—have on countries such as Japan?
Key-Panel Speakers
Larry BRILLIANTCEO, PANDEFENSE ADVISORY / EPIDEMIOLOGIST / PHILANTHROPIST
Gargee GHOSHPRESIDENT, GLOBAL POLICY & ADVOCACY, BILL & MELINDA GATES FOUNDATION
Angela HWANGGROUP PRESIDENT, PFIZER BIOPHARMACEUTICALS GROUP
NISHIMURA Yasutoshi MINISTER IN CHARGE ECONOMIC REVITALIZATION, JAPAN
Alexander KAZAN(MODERATOR) MANAGING DIRECTOR, GLOBAL STRATEGY, EURASIA GROUP
Roundtable Participants
ASAI Eriko PRESIDENT AND CEO, GE JAPAN
Robert FELDMANPROFESSOR, MANAGEMENT OF TECHNOLOGY PROGRAM, TOKYO UNIVERSITY OF SCIENCE
HARADA AkihisaPRESIDENT & REPRESENTATIVE DIRECTOR, PFIZER JAPAN INC.
INADA SeijiGLOBAL HEAD OF STRATEGIC INITIATIVES & JAPAN COUNTRY REPRESENTATIVE, EURASIA GROUP
ITO HitoshiVICE PRESIDENT AND EXECUTIVE OFFICER, HITACHI, LTD.
Chris MARLINPRESIDENT, LENNAR INTERNATIONAL
Scott ROSENSTEINSPECIAL ADVISOR, GLOBAL HEALTH, EURASIA GROUP
SASAKI Nobuhiko CHAIRMAN, JAPAN EXTERNAL TRADE ORGANIZATION (JETRO)
Joshua W WALKER PRESIDENT & CEO, JAPAN SOCIETY
WASHIO EiichiroSTATE MINISTER FOR FOREIGN AFFAIRS, MINISTRY OF FOREIGN AFFAIRS, JAPAN
Christophe WEBERPRESIDENT AND CHIEF EXECUTIVE OFFICER, TAKEDA PHARMACEUTICAL COMPANY LIMITED
KASHIWAKURA Mihoko[MODERATOR] HEAD OF JAPAN RELATIONS, BILL & MELINDA GATES FOUNDATION
Reference Materials
The Access to COVID-19 Tools (ACT) Accelerator
Eurasia reports: research on the return on investment in ACT-A to 10 countries
*1Key-Panel Discussion is an on-the-record panel discussion that is open to the pre-registered audience. The video will be available at gzeromedia.com post-summit.
*2Roundtable discussion is a discussion among VIP participants which is open only to pre-registered summit audience.
*Last name in alphabetical order
*2Roundtable discussion is a discussion among VIP participants which is open only to pre-registered summit audience.
*Last name in alphabetical order